Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genomic Research Center, |
RCV001170004 | SCV001251876 | pathogenic | not provided | 2020-05-03 | criteria provided, single submitter | clinical testing | |
Kariminejad - |
RCV001814277 | SCV001755311 | likely pathogenic | Abnormality of the nervous system | 2021-07-10 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002557468 | SCV003321261 | pathogenic | Cohen syndrome | 2022-02-20 | criteria provided, single submitter | clinical testing | This variant has not been reported in the literature in individuals affected with VPS13B-related conditions. This sequence change creates a premature translational stop signal (p.Gln2311*) in the VPS13B gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in VPS13B are known to be pathogenic (PMID: 15141358, 16648375, 20461111). This variant is not present in population databases (gnomAD no frequency). ClinVar contains an entry for this variant (Variation ID: 915394). For these reasons, this variant has been classified as Pathogenic. |